Aspen Pharmacare Holdings Limited - Announcement

Aspen Pharmacare Holdings Limited - Announcement                                
Aspen Pharmacare Holdings Limited                                               
(Incorporated in the Republic of South Africa)                                  
(Registration number 1985/002935/06)                                            
Share code:  APN   ISIN: ZAE000023586                                           
Aspen Pharmacare is pleased to announce the following Aspen generic anti-       
retrovirals have been registered with the MCC.                                  
Aspen Nevirapine Tablets 200mg                                                  
Aspen Lamivudine Tablets 150mg                                                  
Aspen Lamivudine Solution 100mg/ml                                              
Aspen Zidovudine Tablets 300mg                                                  
Aspen Zidovudine Syrup 50mg/5ml                                                 
Aspen Lamzid (Zidovudine 300mg and Lamivudine 150mg combination tablet)         
They will be added to Aspen"s previously registered anti-retrovirals:           
Aspen Stavudine Capsules 15mg                                                   
Aspen Stavudine Capsules 20mg                                                   
Aspen Stavudine Capsules 30mg                                                   
Aspen Stavudine Capsules 40mg                                                   
Aspen Didanosine (Buffered) Tablets 25mg                                        
Aspen Didanosine (Buffered) Tablets 50mg                                        
Aspen Didanosine (Buffered) Tablets 100mg                                       
Aspen Didanosine (Buffered) Tablets 150mg                                       
Aspen is now in a position to provide cocktail therapies.                       
The newly registered products will be available in the private market by the end
of August and will qualify for the State tender closing in August 2004.         
Stephen Saad, Aspen Pharmacare Holdings Limited                                 
Group Chief Executive                                                           
Tel: (031) 580 8603                                                             
Fax: (031) 580 8640                                                             
Cell:  083 303 4833                                                             
Date: 29/07/2004 02:47:37 PM Supplied by www.sharenet.co.za                     
Produced by the JSE SENS Department